Viemed Healthcare, Inc. (VMD)

Viemed Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	15.38	15.38	11.41	10.24	6.22	9.13
Depreciation & Amortization	29.62	28.61	25.37	21.86	15.63	11.31
Stock-Based Compensation	9.27	9.13	6.29	5.85	5.2	5.15
Other Adjustments	4.83	1.1	-4.33	-0.52	0.82	10.47
Change in Receivables	-2.56	1.16	-6.07	-1.06	-2.56	-7.35
Changes in Inventories	0.11	0.06	0.57	-0.47	0.3	-0.21
Changes in Accounts Payable	0.89	0.48	0.36	-0.86	-0.32	0.13
Changes in Accrued Expenses	0.7	0.26	2.86	4.96	2.55	-4.02
Changes in Income Taxes Payable	-0.84	-4.11	1.73	2.18	1.87	-2.23
Changes in Unearned Revenue	0.22	0.36	0.36	0.85	0.87	0.34
Changes in Other Operating Activities	0.49	-0.5	0.54	2.18	-2.84	-0.23
Operating Cash Flow	57.13	51.92	39.09	45.21	27.75	22.49
Operating Cash Flow Growth	40.14%	32.81%	-13.54%	62.94%	23.36%	-35.93%
Capital Expenditures	-31.21	-39.99	-37.77	-26.09	-22.9	-19.74
Sale of Property, Plant & Equipment	10.43	16.15	10.32	2.59	1.06	0.6
Purchases of Investments	-	-	-1	-0.02	-2.14	-0.6
Proceeds from Sale of Investments	-	-	0.75	-	-	-
Payments for Business Acquisitions	-26.33	-26.33	-3	-28.59	-	-
Investing Cash Flow	-47.12	-50.17	-30.7	-52.11	-23.98	-19.75
Short-Term Debt Issued	13	13	3	8	-	-
Short-Term Debt Repaid	-8	-13	-5	-7.01	-	-
Net Short-Term Debt Issued (Repaid)	5	0	-2	1	-	-
Long-Term Debt Issued	-9	-	9	5	-	-
Long-Term Debt Repaid	-3.86	-0.73	-1.07	-3.72	-5.8	-1.84
Net Long-Term Debt Issued (Repaid)	-12.86	-0.73	7.93	1.28	-5.8	-1.84
Issuance of Common Stock	1.95	1.44	1.02	1.3	0.28	0.11
Repurchase of Common Stock	-16.81	-14.96	-1.07	-0.59	-9.71	-1.43
Net Common Stock Issued (Repurchased)	-14.86	-13.52	-0.05	0.71	-9.43	-1.32
Other Financing Activities	-0.7	-0.54	-0.57	-0.16	-0.04	-2.16
Financing Cash Flow	-10.41	-5.79	-3.69	2.83	-15.27	-5.32
Net Cash Flow	-0.4	-4.04	4.7	-4.08	-11.49	-2.57
Free Cash Flow	25.92	11.93	1.32	19.12	4.85	2.75
Free Cash Flow Growth	117.24%	805.24%	-93.11%	294.21%	76.30%	-87.53%
FCF Margin	9.04%	4.41%	0.59%	10.45%	3.49%	2.35%
Free Cash Flow Per Share	0.64	0.29	0.03	0.47	0.12	0.07
Levered Free Cash Flow	7	-0.63	11.22	17.12	-4.41	-7.36
Unlevered Free Cash Flow	16.26	1.38	6.65	14.8	0.88	-6.19

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q